Cinven
Cinven describes a control-oriented private equity approach focused on growth-oriented, market-leading, cash-generative companies and active value creation. Its stated sectors are Business Services, Consumer, Financial Services, Healthcare, Industrials, and Technology, Media and Telecommunications, with a European focus and selective North American investing.
What stands out about Cinven
Cinven publicly presents a sector- and region-specialist private equity model centered on control positions, active ownership and value creation. Its Strategic Fund 2 targets control positions in high-growth, asset-light European mid-market businesses, primarily in Financial Services, Business Services and TMT.[1][2][3][5][7][8]
What does Cinven invest in?
Cinven is an international private equity firm with a strong European heritage. It was founded in 1977, became independent in 1995 and has been partner-owned since then.
Its business is the management and advising of private equity funds that acquire and build companies, with active ownership and value creation throughout the funds’ ownership period.[1][2]
Cinven states that its flagship strategy invests in control positions in growth-oriented, market-leading, cash-generative companies with resilient characteristics where active management can accelerate growth.
The firm says it invests behind long-term structural trends and combines sector and country specialists to identify untapped potential and implement value-creation plans with portfolio-company management teams.[2][3]
Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.
What should a business owner evaluate before considering a transaction with Cinven?
An owner evaluating Cinven should establish which fund and legal entity would make the investment, how the relevant strategy applies its control and company criteria, and what ownership structure is proposed. The firm’s public materials describe partnerships with founders and management teams, so the proposed rollover, governance rights, management incentives and decision authority should be documented clearly.
Owners should also seek detail on the value-creation plan, the role of Cinven’s sector and regional specialists, any potential add-on strategy, financing assumptions, indemnities, escrow and post-closing obligations. The relevant ownership horizon and exit planning approach should be confirmed for the specific investment.[2][3][5]
What companies does Cinven target?
The flagship strategy is described as targeting control positions in growth-oriented, market-leading, cash-generative companies with resilient characteristics. Strategic Fund 2 targets control positions in high-growth, asset-light opportunities in the European mid-market, primarily across Financial Services, Business Services and TMT.[3][5]
Cinven identifies six core sectors: Business Services, Consumer, Financial Services, Healthcare, Industrials, and Technology, Media and Telecommunications.[1]
Cinven has a European focus and can invest selectively in North America. It operates through offices or regional operations in Frankfurt, London, Luxembourg, Madrid, Milan, New York and Paris, with regional expertise across European and US markets.[1][4]
Cinven’s public materials describe a model that includes acquiring and building companies, as well as implementing value-creation plans with portfolio-company management teams.
The firm’s Strategic Fund 2 announcement states that its first four investments were founder- or employee-owned businesses in which Cinven partnered with founders and management teams to pursue further value creation. Owners should clarify how a proposed investment would be structured and whether additional acquisitions would form part of the relevant plan.[2][5]
Cinven’s official portfolio archive lists companies across Business Services, Consumer, Financial Services, Healthcare, Industrials and TMT. Listed examples include Salsify, Regenity Biosciences, NewDay, Objectway, STADA, TK Elevator, Ufinet International II, Universidad Alfonso X el Sabio and Vitamin Well.[6]
Recent official announcements include Cinven’s agreement to acquire Salsify on 22 July 2026, a cloud-native Product Experience Management software provider with operations spanning North America, Europe and Australia.
On 2 July 2026, Cinven’s portfolio company Vitamin Well Group agreed to combine with EMPWR, with Waterland becoming a minority owner in the combined business. On 12 February 2026, Cinven agreed to make a strategic investment in Regenity Biosciences alongside legacy investor Linden Capital Partners.
Other announcements state that Cinven agreed to make a majority investment in Flint Global on 8 December 2025 and that the transaction represented the second investment from its new mid-market strategy.[7][8][9][10]
What is not clear from Cinven's public investment criteria?
The official Salsify announcement states that financial terms of the acquisition were not disclosed. The official Vitamin Well Group and EMPWR announcement likewise states that financial terms were not disclosed.
The cited Strategic Fund 2 announcement describes target sectors, control positions, asset-light characteristics and European mid-market scope, but does not state a universal minimum revenue, EBITDA, enterprise-value or equity-investment threshold.[5][7][8]
Questions to ask when evaluating Cinven as a buyer or investment partner
Which Cinven fund and legal entity would make the investment?
What are the target revenue, EBITDA, enterprise-value, equity-check and leverage parameters for the relevant strategy?
Does Cinven require control, and what rollover or retained-equity percentage is expected from current owners?
How are management incentives, board rights, reserved matters and add-on acquisition authority structured?
What is the expected ownership horizon and exit planning approach for the relevant investment?
Which operating resources and sector specialists would be assigned to the business?
What transaction terms, financing assumptions, indemnities, escrow and post-closing obligations would apply?
Sources & research notes
- Official website / firm overview
- Services / capabilities
- Investment strategy
- Geography / market coverage
- Transaction size / criteria
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Structure / regulatory context
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.